Hamamatsu University School of Medicine · Department of Clinical Pharmacology · 教授

Research keywordsブレオマイシン・薬理遺伝学・間質性肺炎・薬剤性肺炎・臨床試験・臨床薬理学・肺線維症・肺癌

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial.2025 · Lung cancer (Amsterdam, Netherlands) [巻]201 [頁]108109 （2025年） [査読] 有
• Hypnotics and Mortality in Idiopathic Pulmonary Fibrosis: Hospital and National Data-Based Analysis2025 · Chest [巻]167 （2025年） [査読] 有
• Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial.2024 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology [頁]JCO2400278 （2024年） [査読] 有
• Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II study2024 · BMC pulmonary medicine [巻]24 [号]1 [頁]495 （2024年） [査読] 有

• 2022年8月- 2023年3月 臨床試験の支援2022 · [2]. 肺線維症
• 肺障害・肺線維化における血管内皮細胞と線維芽細胞の相互作用
• 肺血管内皮細胞の低酸素応答による線維化促進の機序解明と治療への応用
• 薬物代謝酵素CYP2A6遺伝子多型に基づいた抗癌剤S1による肺癌治療の有用性

• Official profile